Doha: Hamad Medical Corporation (HMC) intends to establish a joint liaison clinic between joint and rheumatology and orthopedic departments for fracture treatment later this year, in line with the development witnessed by the Osteoporosis Diagnosis and Treatment Services at the Corporation.
The purpose of this clinic is to identify patients suffering from fractures as a result of minor trauma and suffering from osteoporosis and to initiate their treatment to prevent further fractures.
The rheumatology division of HMC uses the latest technology and drugs to diagnose and treat patients with osteoporosis and continues to partner with specialists around the world to ensure that patients in Qatar have access to world-class care.
The head of the rheumatology division of HMC, Dr. Samar Al Emadi said: “There is strong evidence that timely testing is critical for faster diagnosis, more timely treatment and better outcomes in many medical conditions, including osteoporosis. Many people today are better educated on the importance of good bone health and understand that osteoporosis is not just a disease of the elderly. However, many people remain unaware that osteoporosis is a largely preventable disease. Our team is working with international experts to prepare a guideline for treatment osteoporosis as part of efforts to standardize osteoporosis care in Qatar. Last year we launched a national osteoporosis screening program and recently introduced a program that will see all patients aged 50 and over years that have suffered a fracture screened for the disease Fracture Liaison Clinic by the end of the year le of this clinic will be identifying patients with fragility fractures (low impact trauma) who have osteoporosis so that we can start treatment in hopes of preventing further fractures. “
Osteoporosis is often called silent disease as patients rarely have any signs or symptoms until a fracture occurs. Although risk factors for the condition include older age, a family history of osteoporosis, low body weight, smoking, certain medical conditions, and certain medications, such as steroids (cortisone) and sex, with the disease being more common in women, many people with osteoporosis continue to go undiagnosed and untreated.
Dr. Nabeel Abdulla, a consultant in rheumatology, says that health professionals play an important role in educating their patients about bone health. He adds that healthcare professionals who have female patients over the age of 50 should prioritize bone health, noting that early identification and treatment of low bone density is the most effective approach to prevent future fractures. Osteoporosis weakens bones and can lead to painful fractures or severe disability. One in three women and one in five men over the age of 50 may have osteoporosis in their lifetime. The condition can lead to fractures which can be followed by chronic pain, depression, and even reduced life expectancy. Both doctors and patients should be educated about this disease, and especially the early symptoms. Sudden severe back pain (due to a fractured or collapsed vertebrae), gradual loss of height and hunched posture, and fractures that occur with minor trauma should all be considered as possible warning signs. A bone mineral density (BMD) test and / or a fracture risk assessment can be important diagnostic tools and can help guide treatment options. Once the disease is identified, treatment can help strengthen bones and prevent further fractures. “
Dr. Omar Alsaed, associate consultant in rheumatology, said it’s important that patients who have been prescribed osteoporosis medications make sure they take them as directed. Dr Alsaed added that osteoporosis patients should make every effort to attend all scheduled medical appointments, noting that ongoing treatment is an important part of disease management. He said the rheumatology division is working with HMC’s home health care service to provide home care for patients who receive an injection every six months as part of their treatment plan to ensure these patients continue to receive the drug. in time.